Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers.

Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers. Obesity (Silver Spring). 2016 11; 24(11):2278-2288.

View in: PubMed

subject areas

Adult
Anti-Obesity Agents
Biomarkers
Body Mass Index
Body Weight
Cardiovascular System
Dose-Response Relationship, Drug
Double-Blind Method
Endpoint Determination
Exercise
Female
Humans
Liraglutide
Male
Middle Aged
Obesity
Prediabetic State
Quality of Life
Respiratory System
Risk Factors
Treatment Outcome
Weight Loss

authors with profiles

Patrick M O'Neil